These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Tricyclic heteroaromatic systems. Synthesis and benzodiazepine binding activity of 1-substituted-3-methyl- and 3-phenylpyrazolo[4,5-c]quinolin-4-ones. Colotta V; Cecchi L; Melani F; Catarzi D; Filacchioni G; Martini C; Giannaccini G; Tonelli M; Lucacchini A Drug Des Discov; 1992 Jul; 8(4):325-39. PubMed ID: 1332785 [TBL] [Abstract][Full Text] [Related]
24. Synthesis and benzodiazepine receptors affinity of 2,3-dihydro-9-phenyl-1H-pyrrolo[3,4-b]quinolin-1-one and 3-carbethoxy-4-phenylquinoline derivatives. Anzini M; Cappelli A; Vomero S; Cagnotto A; Skorupska M Farmaco; 1992 Feb; 47(2):191-202. PubMed ID: 1324688 [TBL] [Abstract][Full Text] [Related]
25. Benzodiazepine receptor ligands. III. Synthesis and biological evaluation of 2- and/or 3-substituted pyrazolo[5,1-c][1,2,4]benzotriazine 5-oxides. Guerrini G; Costanzo A; Bruni F; Ciciani G; Selleri S; Gratteri P; Costa B; Martini C; Lucacchini A Farmaco; 1999 Jun; 54(6):375-89. PubMed ID: 10576777 [TBL] [Abstract][Full Text] [Related]
26. Tricyclic heteroaromatic systems. Synthesis and A1 and A2a adenosine binding activities of some 1-aryl-1,4-dihydro-3-methyl[1]benzopyrano[2,3-c] pyrazol-4-ones, 1-aryl-4,9-dihydro-3-methyl-1H-pyrazolo[3,4-b]quinolin-4- ones, and 1-aryl-1H-imidazo[4,5-b]quinoxalines. Catarzi D; Cecchi L; Colotta V; Filacchioni G; Martini C; Tacchi P; Lucacchini A J Med Chem; 1995 Apr; 38(8):1330-6. PubMed ID: 7731018 [TBL] [Abstract][Full Text] [Related]
27. Specific inhibition of benzodiazepine receptor binding by some 1,2,3-triazole derivatives. Martini C; Marrucci W; Lucacchini A; Biagi G; Livi O J Pharm Sci; 1988 Nov; 77(11):977-80. PubMed ID: 2852246 [TBL] [Abstract][Full Text] [Related]
28. Synthesis, binding studies, and structure-activity relationships of 1-aryl-and 2-aryl[1]benzopyranopyrazol-4-ones, central benzodiazepine receptor ligands. Colotta V; Cecchi L; Filacchioni G; Melani F; Palazzino G; Martini C; Giannaccini G; Lucacchini A J Med Chem; 1988 Jan; 31(1):1-3. PubMed ID: 2826782 [No Abstract] [Full Text] [Related]
29. Synthesis of 7-(2-dimethylaminovinyl) derivatives of pyrazolo[1,5-a] pyrimidines, as precursors of new tricyclic series. Binding studies of BDZ receptor. Bruni F; Costanzo A; Selleri S; Guerrini G; Giusti L; Martini C; Lucacchini A Farmaco; 1993 Feb; 48(2):309-19. PubMed ID: 8388217 [TBL] [Abstract][Full Text] [Related]
30. Synthesis of 1H-pyrazolo[4,3-d]pyrimidine-7(6H)-ones and pyrazolo-5-carboxamides and interaction with benzodiazepine and adenosine A1 receptors in rat cerebral cortex. Baraldi PG; Casolari A; Manfredini S; Periotto V; Zanirato V; Florio C; Traversa V; Bertelli GM; Borea PA Arzneimittelforschung; 1988 Sep; 38(9):1262-5. PubMed ID: 2852012 [TBL] [Abstract][Full Text] [Related]
31. Synthesis, benzodiazepine receptor binding and molecular modelling of isochromeno[4,3-c]pyrazol-5(1H)-one derivatives. Maggio B; Raffa D; Raimondi MV; Plescia F; Trincavelli ML; Martini C; Meneghetti F; Basile L; Guccione S; Daidone G Eur J Med Chem; 2012 Aug; 54():709-20. PubMed ID: 22795832 [TBL] [Abstract][Full Text] [Related]
32. High affinity central benzodiazepine receptor ligands. Part 2: quantitative structure-activity relationships and comparative molecular field analysis of pyrazolo[4,3-c]quinolin-3-ones. Savini L; Chiasserini L; Pellerano C; Biggio G; Maciocco E; Serra M; Cinone N; Carrieri A; Altomare C; Carotti A Bioorg Med Chem; 2001 Feb; 9(2):431-44. PubMed ID: 11249135 [TBL] [Abstract][Full Text] [Related]
33. Thienylpyrazoloquinolines with high affinity to benzodiazepine receptors: continuous shift from inverse agonist to agonist properties depending on the size of the alkyl substituent. Shindo H; Takada S; Murata S; Eigyo M; Matsushita A J Med Chem; 1989 Jun; 32(6):1213-7. PubMed ID: 2542554 [TBL] [Abstract][Full Text] [Related]
34. Thienylpyrazoloquinolines: potent agonists and inverse agonists to benzodiazepine receptors. Takada S; Shindo H; Sasatani T; Chomei N; Matsushita A; Eigyo M; Kawasaki K; Murata S; Takahara Y; Shintaku H J Med Chem; 1988 Sep; 31(9):1738-45. PubMed ID: 2842502 [TBL] [Abstract][Full Text] [Related]
35. Computer-aided molecular modeling, synthesis, and biological evaluation of 8-(benzyloxy)-2-phenylpyrazolo[4,3-c]quinoline as a novel benzodiazepine receptor agonist ligand. Wang CG; Langer T; Kamath PG; Gu ZQ; Skolnick P; Fryer RI J Med Chem; 1995 Mar; 38(6):950-7. PubMed ID: 7699711 [TBL] [Abstract][Full Text] [Related]
36. Tricyclic heteroaromatic systems. [1]benzopyranopyrrol-4-ones and [1]benzopyrano-1,2,3-triazol-4-ones as benzodiazepine receptor ligands. Synthesis and structure-activity relationships. Colotta V; Cecchi L; Melani F; Filacchioni G; Martini C; Giannaccini G; Lucacchini A J Med Chem; 1990 Sep; 33(9):2646-51. PubMed ID: 2167984 [TBL] [Abstract][Full Text] [Related]
38. Synthesis and binding activity of some pyrazolo[1,5-c]quinazolines as tools to verify an optional binding site of a benzodiazepine receptor ligand. Colotta V; Catarzi D; Varano F; Filacchioni G; Cecchi L; Galli A; Costagli C J Med Chem; 1996 Jul; 39(15):2915-21. PubMed ID: 8709126 [TBL] [Abstract][Full Text] [Related]
39. Studies on specific inhibition of benzodiazepine receptor binding by some C-benzoyl-1,2,3-triazole derivatives. Biagi G; Giorgi I; Livi O; Lucacchini A; Martini C; Scartoni V J Pharm Sci; 1993 Sep; 82(9):893-6. PubMed ID: 8229686 [TBL] [Abstract][Full Text] [Related]
40. [Relationship between the structure, affinity to benzodiazepine receptors and properties of 5-halogenophenyl-1,2-dihydro-3H-1,4- benzodiazepine-2-ones]. Andronati SA; Chepelev VM; Iakubovskaia LN; Val'dman AV; Voronina TA Bioorg Khim; 1983 Oct; 9(10):1357-61. PubMed ID: 6091687 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]